Yu-Cheng Lin1, Pi-Feng Chang, Mei-Hwei Chang, Yen-Hsuan Ni. 1. Department of Pediatrics, Far Eastern Memorial Hospital, Taipei, Taiwan (Y-CL and P-FC); the Departments of Pediatrics, National Taiwan University Hospital, Taipei, Taiwan (M-HC and Y-HN); and the Oriental Institute of Technology, New Taipei City, Taiwan (Y-CL).
Abstract
BACKGROUND: A genome-wide association study identified variants in or near patatin-like phospholipase domain-containing-3 (PNPLA3), neurocan (NCAN), lysophospholipase-like 1 (LYPLAL1), glucokinase regulatory protein (GCKR), and protein phosphatase 1 regulatory subunit 3b (PPP1R3B) that were strongly associated with nonalcoholic fatty liver disease (NAFLD) in adults of European ancestry. OBJECTIVE: We examined these genetic variants in obese children and tested whether their effects on NAFLD are significant in the Taiwanese Han Chinese population. DESIGN: We genotyped PNPLA3 rs738409, NCAN rs2228603, LYPLAL1 rs12137855, GCKR rs780094, and PPP1R3B rs4240624 in 797 obese children aged 7-18 y. NAFLD was identified by liver ultrasonography. We analyzed the effect of these genetic variants on NAFLD. RESULTS: NAFLD was identified in 24% of the recruited obese children. We found significant associations with NAFLD at variants in PNPLA3 and GCKR but not in NCAN, LYPLAL1, and PPP1R3B. Multiple logistic regression analysis showed that, after control for the effects of age- and sex-adjusted body mass index, waist-to-hip ratio, sex, and PNPLA3 rs738409 polymorphism, the variant GCKR rs780094 TT genotype independently increased the OR of NAFLD by 1.997 (95% CI: 1.196, 3.335; P = 0.008) compared with the CC genotype. Subjects with the variant GCKR rs780094 TT genotype had a higher mean serum alanine aminotransferase concentration than did those with the CC genotype (30.8 ± 34.7 compared with 22.2 ± 18.6 IU/L; P = 0.01). CONCLUSIONS: By studying the genetic variants of obese Taiwanese children, we confirmed that the genetic variants in GCKR rs780094 and PNPLA3 rs738409, but not in NCAN rs2228603, LYPLAL1 rs12137855, and PPP1R3B rs4240624, are associated with an increased risk of NAFLD. GCKR and PNPLA3 variants are the common genetic factors that may confer susceptibility to NAFLD in obese individuals across multiple ethnic groups.
BACKGROUND: A genome-wide association study identified variants in or near patatin-like phospholipase domain-containing-3 (PNPLA3), neurocan (NCAN), lysophospholipase-like 1 (LYPLAL1), glucokinase regulatory protein (GCKR), and protein phosphatase 1 regulatory subunit 3b (PPP1R3B) that were strongly associated with nonalcoholic fatty liver disease (NAFLD) in adults of European ancestry. OBJECTIVE: We examined these genetic variants in obesechildren and tested whether their effects on NAFLD are significant in the Taiwanese Han Chinese population. DESIGN: We genotyped PNPLA3rs738409, NCANrs2228603, LYPLAL1rs12137855, GCKRrs780094, and PPP1R3Brs4240624 in 797 obesechildren aged 7-18 y. NAFLD was identified by liver ultrasonography. We analyzed the effect of these genetic variants on NAFLD. RESULTS: NAFLD was identified in 24% of the recruited obesechildren. We found significant associations with NAFLD at variants in PNPLA3 and GCKR but not in NCAN, LYPLAL1, and PPP1R3B. Multiple logistic regression analysis showed that, after control for the effects of age- and sex-adjusted body mass index, waist-to-hip ratio, sex, and PNPLA3rs738409 polymorphism, the variant GCKRrs780094 TT genotype independently increased the OR of NAFLD by 1.997 (95% CI: 1.196, 3.335; P = 0.008) compared with the CC genotype. Subjects with the variant GCKRrs780094 TT genotype had a higher mean serum alanine aminotransferase concentration than did those with the CC genotype (30.8 ± 34.7 compared with 22.2 ± 18.6 IU/L; P = 0.01). CONCLUSIONS: By studying the genetic variants of obese Taiwanese children, we confirmed that the genetic variants in GCKRrs780094 and PNPLA3rs738409, but not in NCANrs2228603, LYPLAL1rs12137855, and PPP1R3Brs4240624, are associated with an increased risk of NAFLD. GCKR and PNPLA3 variants are the common genetic factors that may confer susceptibility to NAFLD in obese individuals across multiple ethnic groups.
Authors: Julien Rousseaux; Alain Duhamel; Julie Dumont; Jean Dallongeville; Denes Molnar; Kurt Widhalm; Yannis Manios; Michael Sjöström; Anthony Kafatos; Christina Breidenassel; Marcela Gonzales-Gross; Magdalena Cuenca-Garcia; Laura Censi; Marcos Ascensión; Stefaan De Henauw; Luis A Moreno; Aline Meirhaeghe; Frédéric Gottrand Journal: J Lipid Res Date: 2015-07-01 Impact factor: 5.922
Authors: Ludovico Abenavoli; Natasa Milic; Laura Di Renzo; Tomislav Preveden; Milica Medić-Stojanoska; Antonino De Lorenzo Journal: World J Gastroenterol Date: 2016-08-21 Impact factor: 5.742
Authors: Giuseppina R Umano; Sonia Caprio; Anna Di Sessa; Naga Chalasani; Daniel J Dykas; Bridget Pierpont; Allen E Bale; Nicola Santoro Journal: Am J Gastroenterol Date: 2018-02-27 Impact factor: 10.864